Guardant Health (GH) Liabilities and Shareholders Equity (2017 - 2026)

Guardant Health has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $1.9 billion in Q2 2026.

• Quarterly Liabilities and Shareholders Equity rose 43.57% year-over-year to $1.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.1 billion (up 24.87% YoY) and the FY2025 annual result came in at $2.0 billion, up 35.54% from the prior year.
• Liabilities and Shareholders Equity held at $1.9 billion in Q2 2026 per GH's latest filing, from $1.9 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $2.1 billion in Q1 2022 and troughed at $1.3 billion in Q3 2025.
• A 5-year average of $1.7 billion and a median of $1.7 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2026: Liabilities and Shareholders Equity declined 29.02% in 2023, then jumped 43.57% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $1.6 billion in 2022, then advanced by 10.96% to $1.8 billion in 2023, then slipped by 16.84% to $1.5 billion in 2024, then soared by 35.54% to $2.0 billion in 2025, then decreased by 5.03% to $1.9 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $1.9 billion, $1.9 billion, and $2.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.